435643
Ethyltrimethoxysilane
≥97%
Synonym(s):
Dow Corning® product 1-6321
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Linear Formula:
C2H5Si(OCH3)3
CAS Number:
Molecular Weight:
150.25
EC Number:
MDL number:
UNSPSC Code:
12352103
PubChem Substance ID:
Recommended Products
Assay
≥97%
form
liquid
refractive index
n20/D 1.384 (lit.)
bp
123-124 °C (lit.)
density
0.94 g/mL at 25 °C (lit.)
SMILES string
CC[Si](OC)(OC)OC
InChI
1S/C5H14O3Si/c1-5-9(6-2,7-3)8-4/h5H2,1-4H3
InChI key
SBRXLTRZCJVAPH-UHFFFAOYSA-N
Legal Information
Repackaged by Aldrich Chemical Company, Inc. Manufactured by Dow Corning Corporation, U.S.A.
Dow Corning is a registered trademark of The Dow Chemical Company or an affiliated company of Dow
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Eye Irrit. 2 - Flam. Liq. 3
Storage Class Code
3 - Flammable Liquids
WGK
WGK 3
Flash Point(F)
80.6 °F - closed cup
Flash Point(C)
27 °C - closed cup
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Di Zhou et al.
Journal of chromatography. A, 1627, 461423-461423 (2020-08-22)
A novel stationary phase co-modified with N-isopropyl acrylamide (NIPAM) and 3-aminophenylboronic acid copolymer on the silica was synthesized through atom transfer radical polymerization (ATRP) reaction for performing mixed-mode and boronate affinity chromatography. The prepared functionalized silica was characterized using Fourier
Kellie I McConnell et al.
Journal of controlled release : official journal of the Controlled Release Society, 194, 113-121 (2014-09-03)
There is an unmet clinical need to increase lung transplant successes, patient satisfaction and to improve mortality rates. We offer the development of a nanovector-based solution that will reduce the incidence of lung ischemic reperfusion injury (IRI) leading to graft
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service